As of September 2026 Inhibikase Therapeutics has a market cap of โน29.40 Billion. This makes Inhibikase Therapeutics the world's 8465th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Sep 21st, 2026 the market cap of Inhibikase Therapeutics was reported to be: